Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1148 participants.
Also called NCT07536802
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,148 participants
- Registry
-
NCT07536802
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT07536802. Randomized; no masking; primary purpose treatment. Start 2025-06-01 (actual); primary completion 2026-05-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
- Acronym
- AMPACT
- Condition
- ST-Segment Elevation Myocardial Infarction (STEMI)
- Condition
- No-Reflow Phenomenon
- Condition
- Coronary Slow Flow
- Condition
- Acute Myocardial Infarction
- Intervention (Drug)
- Adenosine pre-medication
- Intervention (Other)
- Standard care
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct07536802- Content hash
c169d7a2e5502beffaab6bc9411f48dfc66f6d525b09b8574202aa3176ac8ab3